{"id":"W2599371299","doi":"10.1200/jco.2013.31.15_suppl.e11597","title":"Bevacizumab for advanced breast cancer: Hope, hype, and hundreds of headlines.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa; Ottawa Hospital; Queen's University; University of Toronto","funders":"","keywords":"Medicine; Bevacizumab; Breast cancer; Newspaper; Headline; Food and drug administration; Family medicine; Clinical trial; Cancer; Oncology; Internal medicine; Advertising; Pharmacology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004913772,0.0002453573,0.0003094114,0.005467273,0.0006659926,0.002456703,0.000342169,0.0006774866,0.01272605],"category_scores_gemma":[0.03167326,0.0002904227,0.0003590199,0.007592284,0.0008780207,0.002833483,0.0007282777,0.0004590102,0.00269626],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001072431,"about_ca_system_score_gemma":0.001353686,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002614412,"about_ca_topic_score_gemma":0.01011187,"domain_scores_codex":[0.997681,0.0006792189,0.0005489328,0.0001175253,0.0008588981,0.0001144233],"domain_scores_gemma":[0.9458153,0.0316603,0.01410958,0.0004610089,0.00659406,0.001359745],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001196246,0.0001020247,0.2327385,0.01153341,0.0002294208,0.002066028,0.007720105,0.00006030812,0.001506014,0.001825809,0.2922437,0.4487785],"study_design_scores_gemma":[0.00007516875,0.0002198833,0.4944953,0.01146774,0.0003803147,0.00549675,0.02098724,0.0002503141,0.0009470299,0.0008926744,0.4647398,0.0000478081],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"commentary","genre_scores_codex":[0.4017746,0.3221585,0.001664823,0.1376943,0.007647382,0.0006428193,0.0256646,0.0002758615,0.1024771],"genre_scores_gemma":[0.7447327,0.1508398,0.003942133,0.04323437,0.00668492,0.0004512978,0.00991834,0.0002422059,0.03995424],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.01272605,"threshold_uncertainty_score":0.04257286,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.105162011812842,"score_gpt":0.5141664109434135,"score_spread":0.4090043991305716,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}